Sensitivity of oocyte-expressed epithelial Na+ channel to glibenclamide  by Schnizler, Mikael et al.
Sensitivity of oocyte-expressed epithelial Na+ channel to glibenclamide
Mikael Schnizler*, Andreas Berk, Wolfgang Clauss
Institut fu¨r Tierphysiologie der Justus-Liebig-Universita¨t Giessen, Wartweg 95, D-35392 Giessen, Germany
Received 30 July 2002; received in revised form 19 November 2002; accepted 4 December 2002
Abstract
The effect of glibenclamide on heterologously expressed amiloride-sensitive sodium channels (ENaCs) was investigated in Xenopus
oocytes. The ENaC is a heteromer and consists of a-, h- and g-subunits and the a- and h-subunits have previously been shown to confer
sensitivity to glibenclamide. We coexpressed either colonic rat a- (ra) or guinea-pig a-subunit (gpa) with Xenopus hg-subunits. The gpaxhg
was significantly stimulated by glibenclamide (100 AM) (184F 15%), whereas the ra-combination was slightly down-regulated by the
sulfonylurea (79F 4%). The stimulating effect did not interfere with Na+-self-inhibition resulting from intracellular accumulation of Na+-
ions. We exchanged cytosolic termini between both orthologs but the gpa-chimera with the termini from rat retained sensitivity to
glibenclamide. The effect of glibenclamide on Xenopus ENaC (xENaC) was inhibited by ADP-h-S but not by ATP-g-S, when applied
intracellularly. Intracellular loading with Na+-ions after inhibition of Na+/K+-ATPases with ouabain prevented an up-regulation of ENaC
activity by glibenclamide. Pretreatment of oocytes expressing xENaC with edelfosine (ET-18-OCH3) slightly reduced stimulation of Iami
(118F 12%; control: 132F 9%) while phosphatidylinositol-4,5-biphosphate (PIP2) significantly reduced the effect of glibenclamide to
101F 3%.
D 2002 Elsevier Science B.V. All rights reserved.
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1. Introduction
Transcellular electrogenic Na+ transport in tight epithelia
as in the distal nephron, the distal colon or in the lung is
limited by apical Na+-selective channels (ENaCs). The
functional channels comprise homologous a-, h- and g-
subunits which share a topology of two cytosolic termini,
two transmembranous domains and a large extracellular
loop. Regulation of ENaCs has been subject to intensive
studies and in this regard proteins which associate with
these channels recently attracted increasing attention [1,2].
Among such factors, ATP-binding cassette (ABC) pro-
teins were proposed to play a possible role in regulation of
ENaCs. An interaction between ENaC and the cystic fib-
rosis regulator (CFTR), a member of ABC protein family,
was suggested to down-regulate apical sodium permeabil-
ities [3–6]. Recently, glibenclamide, a high-affinity inhib-
itor of sulfonylurea receptors (SUR) but a low-affinity
inhibitor of CFTR [7], was reported to stimulate hetero-
logously expressed ENaCs in Xenopus oocytes [8]. While
the ENaC from the Xenopus nephron (xahg) was strongly
activated by this sulfonylurea, the colonic rat ENaC (rahg)
was insensitive to glibenclamide. This remarkable sensitiv-
ity to this sulfonylurea was conferred by the xa- and xh-
subunits. Patch-clamp experiments in the outside-out con-
figuration indicated that glibenclamide increased the NPo
product (N = number of channels; Po = open probability) but
single-channel conductance remained unaltered [8]. Equally,
a superfusion of ENaC-expressing oocytes with glibencla-
mide did not affect single-channel behaviour in cell-attached
patches. The authors concluded that glibenclamide may act
directly on the ENaCs or on channel-associated proteins
instead of triggering a diffusion of intracellular second
messengers after binding to distant membrane receptors.
In the present study, we express ENaCs in oocytes of
Xenopus laevis and investigate the effect of glibenclamide
on further subunit combinations using two-electrode volt-
age-clamp technique. We expressed heteromeric channels
composed of an a-subunit that we have cloned from guinea-
pig colon (gpa) [9] and xhg and compare those with the
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sulfonylurea-insensitive combination of rat a with xhg. To
investigate whether the stimulating effect of glibenclamide
is triggered from within the cell, we took advantage of the
difference of both orthologs in sensitivity to glibenclamide
and switched cytosolic domains between ra- and gpa-
subunits. Furthermore, we investigated the hypothesis of
sulfonylurea receptors or related proteins with ABCs to bind
glibenclamide and hence to modulate ENaCs.
Phospholipids have been shown to be important regu-
lators of ion transporters and channels [10]. These lipids
have to be inserted into the membranous bilayer where they
interact directly with membrane proteins on the basis of
electrostatics. The role of phospholipids in the glibencla-
mide-induced stimulation of ENaCs was investigated by
inhibition of PIP-degrading phospholipase C as well as
direct application of phosphatidylinositol-4,5-biphosphate
(PIP2).
Our study provides evidence that glibenclamide controls
ENaC activity by a mechanism which is restricted to the
oocyte membrane or associated elements. The effect is
likely not to be transduced by a second-messenger-mediated
modification of cytosolic parts of the a-subunits.
2. Materials and methods
2.1. Expression of ENaC in X. laevis oocytes
Capped cRNA (0.1 ng each) for a-, h- and g-subunits of
Xenopus ENaC, rat aENaC, guinea-pig aENaC or chimeric
rat/guinea-pig a-subunits were injected into stage V/VI
oocytes of X. laevis [9,11,12]. Injected oocytes were kept
in storage solution (10 mM NaCl, 80 mM NMDG, 3 mM
KCl, 2 mM CaCl2, 2.5 mM pyruvate, 0.08 mM penicillin
and 0.03 mM streptomycin, pH = 7.4 adjusted with HCl) for
24–48 h at 14 jC.
2.2. Electrophysiological measurements with two-electrode
voltage-clamp technique
For two-microelectrode voltage-clamp experiments, two
bathing solutions were used: high Na+ Ringer: 90 mM
NaCl, 1 mM KCl, 2 mM CaCl2 and 5 mM HEPES (pH
7.4). Low Na+ Ringer: 20 mM NaCl, 1 mM KCl, 2 mM
CaCl2, 70 mM NMDG and 5 mM HEPES (pH 7.4). Oocytes
were continuously superfused at a flow rate of 3 ml/min.
The membrane potential was clamped to a holding
potential of 0,  20 or  60 mV with a voltage-clamp
amplifier (OC-725B Oocyte clamp, Warner Instrument
Corp.) and controlled by a personal computer via CED
1401 (CED, Cambridge, UK). The current sensitive to 10
AM amiloride (Iami) was determined. Glibenclamide was
used at a concentration of 100 AM (from 0.2 M stock
solution in dimethyl sulfoxide). The current difference
between the respective decreases in response to amiloride
were considered as effect of glibenclamide. Results are
reported as meansF S.E. and represent the mean of n
independent experiments with oocytes originating from N
different donors. The results were analyzed with the Stu-
dent’s t-test or paired t-test and values which are signifi-
cantly different are indicated.
2.3. Construction of chimeric rat/guinea-pig a-subunits
Using PCR, a BSPE1 restriction site was introduced into
gpa cDNA sequence at amino acid position 585–589
(sense: cggttccggagccgg; antisense: ccggctccggaaccg).
SacII restriction sites were introduced into gpa cDNA
(sequence position 224–228) and into ra cDNA (sequence
position 285–290) (sense: caaccgcggaagacg; antisense:
cgtcttcccgcgttg) [13]. All constructs were cloned into
pSDEasy [14].
2.4. Chemicals and enzymes
Amiloride, ATP-g-S; ADP-h-S, glibenclamide, ouabain
and PIP2 were obtained from Sigma. Edelfosine (ET-18-
OCH3) was obtained from Calbiochem Corp.
3. Results
3.1. Specific a-subunits mediate the effect of glibenclamide
The activity of heterologously expressed ENaCs in the
membranes of oocytes is down-regulated by time-dependent
autoregulative processes that are related to extra- and intra-
cellular Na+ concentrations [15]. In orientating experiments,
superfusion of oocytes expressing Xenopus ahgENaC
(xENaC) with 100 AM glibenclamide stimulated the ami-
loride-sensitive part of the current (Iami) to 190F 15%
(n = 6) even after the clamp current (Im) had down-regulated
Fig. 1. Original current recording from gpaxhgENaC-expressing oocyte.
The current sensitive to 10 AM amiloride was determined before and after
glibenclamide (100 AM) was added. The holding potential was  60 mV.
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to a steady-state value at a holding potential of  60 mV in
response to accumulation of intracellular Na+ (90 mM Na+
extracellular). To investigate the role of the a-subunits for
the sensitivity to glibenclamide, we coexpressed two further
a-subunits, the colonic rat a (ra) and guinea-pig a (gpa)
with xhg-subunits. Glibenclamide 100 AM activated the
gpaxhg hybrid channel to 184F 13% (Fig. 1) and thus to a
similar degree as the xENaC, whereas the raxhg combina-
tion was found to be slightly reduced by this sulfonylurea
(79F 5%; n = 6). To reduce accumulation of intracellular
Na+, we exposed oocytes to solutions with low Na+ content.
With 20 mM Na+ in the bath, the oocytes expressing
gpaxhg or raxhg exhibited membrane potentials of
 8.8F 1 mV (n = 28) and  5.8F 1 mV (n = 23), respec-
tively. To avoid channel rundown in response to cytosolic
accumulation of Na+, the oocytes were clamped to a holding
potential of 0 mV. After Im had stabilized, membrane
potentials were clamped to  20 mV for 5 min followed
by the return to 0 mV (Fig. 2A). The clamp protocol was
executed again in the presence of glibenclamide. Fig. 2B
shows the immediate current values at the beginning of the
 20-mV step and after 5 min. Im in oocytes expressing
raxhgENaC was significantly down-regulated within 5 min
(P < 0.01) and this was not affected by glibenclamide
(n = 10; N = 4). Activity of gpaxhgENaC was slightly
down-regulated during the clamp step but the absolute
current values were significantly increased by glibenclamide
(P < 0.005; n = 12; N = 4) (Fig. 2B).
To address the question of whether modifications of the
intracellular domains transduct the stimulation, we took
advantage of the regulatory differences of both hybrid
channels and constructed r/gpa-chimeras by exchanging
the cytosolic termini between these two orthologs. These
constructs were coexpressed with the xhg and tested for
their sensitivity to glibenclamide. Fig. 3 shows the mean
changes in Iami induced by glibenclamide for the different
Fig. 2. Glibenclamide and channel rundown in response to intracellular Na+ accumulation. Shown are current traces from oocytes expressing gpaxhg- or raxhg-
ENaC (A). To reduce intracellular accumulation of Na+, bath solution contained 20 mM NaCl and oocytes were voltage-clamped to a holding potential of 0 mV.
After membrane potential shortly (5 min) was clamped to  20 mVand Im re-equilibrated after return to 0 mV glibenclamide (100 AM) was added. (B) Current
values measured before and during superfusion with glibenclamide at start and after 5 min of the  20-mV clamp step (n= 12; N= 4). *: Significantly
downregulated, P< 0.01; **: significantly downregulated, P < 0.005.
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channel combinations at a holding potential of  20 mVand
20 mM Na+ in the bath. An increased amplitude of Iami in
response to glibenclamide was observed in oocytes that
expressed channels with gpa-subunit (184F 15%; n = 14;
N = 4) or the chimera which contained the transmembranous
domains and the extracellular loop of the gpa-isoform
(243F 15%; n = 12; N = 4). While glibenclamide signifi-
cantly reduced Iami in oocytes expressing raxhgENaC
(79F 4%; n = 13; N = 4), the activity of channels containing
the ra-construct with both cytosolic termini originating from
the guinea pig was not affected by the compound
(98F 13%; n = 13; N = 4) (Fig. 4).
3.2. Are ABC-related proteins involved in mediating the
glibenclamide effect?
SURs possess two ABCs in their cytosolic segments, the
NBF1 and NBF2, which exhibit affinity to ATP and ADP
[16]. We tested whether non-hydrolysable analogs of these
nucleotides affect the activation of ENaCs by glibenclamide.
Oocytes expressing the xENaC were injected with ATP-g-S
or ADP-h-S, respectively. The increase in Iami in response to
100 AM glibenclamide was determined and compared to data
obtained from control oocytes. As shown in Fig. 5, ATP-g-S
at a cytosolic concentration of approximately 5 mM did not
significantly affect the glibenclamide-induced Iami. In con-
trast, after an injection of ADP-h-S (final f 5 mM intra-
cellular), Iami decreased significantly by approximately 24%
in response to glibenclamide. In orientating experiments, we
examined if the reduced response of Iami to glibenclamide
after ADP-h-S treatment was due to an interference with the
action of Na+/K+-ATPases followed by Na+ loading of the
oocytes. An exposure of xENaC-expressing oocytes to 1 mM
ouabain was sufficient to abolish stimulation of Iami by
glibenclamide (only 2F 2%; N = 2; n = 6), but the sulfony-
lurea did not induce a reduction of current as observed in the
ADP-h-S experiments. An injection of ADP-h-S lowered Vm
in all oocytes from + 9.3F 1.3 mV in control to  2.7F 2.8
mV (with 90 mMNa+ extracellular). This indicated that Na+/
K+-pump activity was not shut down by ADP-h-S and thus
no Na+ loading of the oocytes. We tested for the effect of
extracellular non-hydrolysable adenosine nucleotides and 30
min pretreatment of xENaC-expressing oocytes with 1 mM
extracellular ATP-g-S or ADP-h-S in the presence of 1 mM
Mg2 +-ions [16] did not significantly alter the effect of
glibenclamide on activity of xENaC (control: 143F 10%;
ATP-g-S: 133F 10% and ADP-h-S: 143F 10%; n = 6–10;
N = 3).
3.3. Phospholipids reduced the effect of glibenclamide
There is evidence that phospholipids (PIPs) play a
prominent role in regulation of diverse ion channels
[10,17,18]. First, we increased the level of PIPs in the
plasma membrane by application of a selective inhibitor
of phosphatidyl-inositol-specific phospholipase C. A 30-
min preincubation of oocytes expressing xENaC with 10
Fig. 3. Comparison of the effect of glibenclamide on different heteromeric
channels. a-subunits from rat and guinea pig or chimeric constructs with
exchanged cytosolic termini were coexpressed with Xenopus h- and g-
subunits. The current sensitive to 10 AM amiloride (Iami) and the effect of
glibenclamide (100 AM) were measured at a holding potential of  20 mV
(n= 12–15; N= 4). *: Significantly different from control, P < 0.01; **:
significantly different from control, P < 0.005.
Fig. 4. Original current recording obtained in ENaC-expressing oocyte.
Oocyte coexpressed chimeric ra (both cytosolic termini originating from
guinea pig a-isoform) with Xenopus hg. The holding potential was  20
mV. Note: In contrast to gpaxhg, this channel is not stimulated by
glibenclamide (100 AM).
Fig. 5. Effect of intracellular non-hydrolysable adenosine nucleotides.
xENaC-expressing oocytes were injected with either 50 nl of 50 mM ATP-
g-S or 50 mM ADP-h-S in H2O. The holding potential was  20 mV. After
clamp current reached the maximum in response to 100 AM glibenclamide,
Iami was determined (n= 6; N= 3). Control oocytes were injected with an
equal amount of Li+-ions. *: Significantly different from control, P < 0.005.
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AM ET-18-OCH3 decreased the average stimulatory effect
of glibenclamide (Fig. 6). An additional injection of PIP2
(50 nl PIP2; 25 mM in H2O) into ET-18-OCH3-pretreated
oocytes revealed a more pronounced and significant reduc-
tion of the glibenclamide effect (Fig. 6) [19].
4. Discussion
Glibenclamide, a high-affinity inhibitor of SUR was
recently tested for its effect on the epithelial sodium
channels. Besides, native amiloride-sensitive sodium con-
ductances in the Xenopus kidney A6 cell line, the xENaC
and the human ENaC heterologously expressed in Xenopus
oocytes were stimulated by glibenclamide. Interestingly, the
oocyte-expressed ratENaC could not be activated by gli-
benclamide and combinations with subunits from Xenopus
revealed that the xa- and the xh-subunit confer the sensi-
tivity to glibenclamide [8]. We coexpressed Xenopus hg-
subunits with an a-subunit either from rat (raxhg) or
with an a-subunit originating from the guinea-pig colon
(gpaxhg) [9,11]. While the raxhg remained insensitive to
glibenclamide, as expected, the gpaxhg was activated as
the xENaC.
High cytosolic Na+ concentrations decrease activity of
ENaCs due to autoregulative processes. These mechanisms
are possibly mediated via Na+-sensing receptors and appear
as well in oocytes [20–22]. We tested whether glibencla-
mide releases gpaxhg from such Na+-self-inhibition. We
prevented accumulation of Na+-ions by superfusion with
low-Na+ solution (20 mM), which is similar to physiological
intracellular Na+ concentrations in oocytes. The clamp
potential was shifted from holding potential of 0 to  20
mV and held for 5 min. Although the initial amplitude of Im
in response to the  20-mV step was increased, the time-
dependent down-regulation seemed to be not affected by
glibenclamide. Thus, the stimulation by glibenclamide is
possibly due to other mechanisms. We switched the intra-
cellular termini between the gpa- and the rata-subunit and
tested channels containing these constructs for their sensi-
tivity to glibenclamide. A substitution of both of the two
cytosolic gpa-termini by the respective termini from the rat
isoform did not prevent the stimulation of Iami by gliben-
clamide. The effect on channels with the chimeric gpa was
even more pronounced which may result from the weaker
basal expression in our experiments (Fig. 3). The chimera
with the extracellular loop and the transmembranous
domains from the rat and intracellular parts from gpa was
insensitive to glibenclamide. These findings coincide to
some degree with conclusion of a previous study that
extracellular glibenclamide mediates activation of ENaCs
by either direct binding to the channel proteins or mem-
brane-restricted associated factors [8]. The mechanisms of
stimulation may only be exerted when certain conforma-
tional changes take place or with specific binding affinities
that demand an integrity of the extracellular part of the
protein. At least a modification of cytosolic parts of the a-
ENaC-subunits as, for example, phosphorylation initiated
by a distinct receptor which triggers the diffusion of second
messengers seems not to be likely.
One putative regulatory protein that is thought to interact
with ENaCs is the cystic fibrosis transmembrane conduc-
tance regulator (CFTR) [23]. In native epithelia, ENaC is
inhibited when CFTR is activated [24–26]. The PKA-
dependent stimulation of CFTR has been attributed to an
interaction of the C-terminal PDZ-binding domain with
scaffolding proteins and ezrin, a putative PKA anchoring
protein [27–30]. Such an assemblage with PDZ- or similar
domain factors could offer a novel way of how ABC
proteins control ENaCs. SUR-type proteins could associate
in scaffolding complexes that sequester, e.g. protein kinases
or phosphatases in close proximity with ENaC and organize
physically signal transduction pathways.
The glucose-induced insulin secretion in the pancreatic
h-cells underlies a quite complex control of cytosolic
ATP/ADP ratio [7,16]. SUR1 builds a subunit of the
KATP-channel and binds ATP at NBF1 and ADP at the
NBF2 in a cooperative manner. Glibenclamide possibly
modulates the cooperative interaction of the NBFs of
SUR1. SURs and ENaCs are coexpressed in renal epi-
thelia where they are possibly colocalized in renal collect-
ing duct principal cells [31]. Recently, heterologously
expressed SUR was reported to control the processing
and transport of ENaCs to the oocyte membrane in a
chaperone-like manner [32]. This may suggest that gli-
benclamide binds to a SUR or to another as yet unidenti-
fied ABC protein and these interact with ENaCs in the
Xenopus oocyte membrane.
To determine the involvement of any SUR-related ABC
protein in the stimulation of ENaCs by glibenclamide, we
Fig. 6. Effect of ET-18-OCH3 and PIP2 on glibenclamide-induced increase
in Iami. Oocytes expressing xENaC were either incubated for 30 min in 10
AM ET-18-OCH3 (ET-18) or additionally injected with 50 nl of PIP2 (PIP2)
(25 mM in H2O). Oocytes were clamped to a holding potential of  20 mV
and then superfused with 100 AM glibenclamide. The current sensitive to
10 AM amiloride was determined. The number of measurements was n= 7–
8, N = 3. **: Significantly different from control, P< 0.005.
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applied non-hydrolysable derivatives of ATP and ADP. An
extracellular application of ATP-g-S or ADP-h-S had no
significant impact on the glibenclamide-induced stimulation
of ENaC. However, an intracellular application of ADP-h-S
but not ATP-g-S abolished the stimulation of Iami in
response to glibenclamide. Meanwhile, KATP channels serve
as a prototypic example for cytosolic ATP/ADP ratio [7,16].
SUR1 builds a subunit of the complex SUR-mediated
regulation by intracellular adenosine nucleotides [17].
Because the inhibitory and stimulatory impacts of adenosine
nucleotides on SUR-mediated regulation on ion channels
are still under debate, it was difficult to predict whether ATP
or ADP should positively or negatively influence the
glibenclamide effect upon oocyte-expressed ENaCs. First
of all, an interference with the activity of the Na+/K+-
ATPases has to be taken into consideration. However, as
we have shown, an inhibition of the Na+/K+-pumps by
ouabain prevented an increase of Iami in response to gliben-
clamide. In our experiments, an injection of ADP-h-S
depolarized membrane potentials, an opposite effect from
what one expects from an inhibition of Na+/K+-ATPases. In
our opinion, this may indicate that the ADP-h-S effect was
not due to the shutdown of pump activity. Further, both
adenosine nucleotides were intracellularly offered as Li+-
salts. Li+-ions are known to accumulate in the cells; never-
theless, only the ADP-h-S decreased significantly the
response of Iami to glibenclamide. However, our experi-
ments provided no direct evidence that ADP-h-S did not
affect activity of Na+/K+-ATPases.
Among the adenosine nucleotides, ATP plays a central
role in polymerization and depolymerization processes of
cytoskeletal elements as the actin filaments. An involvement
of actinous elements had been postulated in regulation of
ENaCs and other ion channels [33,34]. Thus, the inhibitory
effect of ADP-h-S may also be due to an interference with
such cytoskeletal elements. This would stress the impor-
tance of the transmembranous domains and the proximate
sections of the ENaC proteins.
PI-kinases generate PIPs from phosphorylation of phos-
phatidylinositol by an ATP-consuming process [35,36]. The
ABC proteins seem to link phospholipid metabolism to the
residual cellular metabolism by regulating ATP sensitivity
of ion channels as, e.g., the inward rectifying KATP [17,18].
The action of PIPs on ion channels requires their insertion
into the plasma membrane where they interact with cyto-
solic parts of the channel proteins on the basis of electro-
statics [37,38]. In these cases, membrane-inserted PIPs
interact directly through their negatively charged head
groups with the cytosolic portion of channel proteins or
associated factors. In the present study, an increase of PIP2
levels prevented the stimulation of Iami by glibenclamide. In
any case, inhibition of phosphatidyl-inositol-specific phos-
pholipase C with ET-18-OCH3 accumulates PIP2 but
reduces diacylglycerol (DAG) and 1,4,5-inositol triphos-
phate (IP3). This may affect further signaling pathways
and, for example, an inhibiting effect of a depletion in
DAG has to be taken into consideration. Because PIP-
mediated control is not a common feature of all kinds of
membrane proteins, the regulatory impact on the oocyte-
expressed ENaCs may be assessed as a further indicator for
an involvement of SUR-related membrane receptors [10].
PIP2 additionally inhibits a broad spectrum of F-actin-
severing proteins and therefore acts as a stabilizer of
filaments [34]. However, from our data, we cannot exclude
the possibility that assembly and disassembly of the actin
cytoskeletal network interfere with the stimulatory effect of
glibenclamide on oocyte-expressed ENaCs.
In summary, these data indicate that the extracellular loop
or transmembranous domains of a-ENaC confer sensitivity
to glibenclamide. Glibenclamide does not interfere with
Na+-self-inhibition. The mechanism proved to be influenced
by adenosine nucleotides and this sensitivity was possibly
not due to down-regulation of Na+/K+-pumps. An increase
of PIP2 after exposure to ET-18-OCH3 abolished the stim-
ulation of ENaCs by glibenclamide. Whether ABC-related
proteins and/or the actin cytoskeleton mediate the effect of
glibenclamide cannot be decided at this point.
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